Pay in 4 interest-free payments of $25.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
is an enoyl-(acyl-carrier protein) reductase fabl inhibitor potentially for the treatment of acute bacterial skin
MLKL inhibitor
PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary Inflammation
twice a day
AZD-2461 (0
Dactinomycin - CAS# 50-76-0 Catalog No.:M6979-10 is an enoyl-(acyl-carrier protein) reductaseDactinomycin, CAS No. 50 76 0, is the most significant member of actinomycines, which are a class of polypeptide antibiotics isolated from soil bacteria of the genus Streptomyces. As one of the older chemotherapy drugs, it has been used for many years. Actinomycin D was the first antibiotic shown to have anti cancer activity. It was first isolated by Selman Waksman and his co worker H. B. Woodruff in 1940. It was approved by the US FDA on December 10,